Characterization of a Tumor Necrosis Factor-Responsive Element Which Down-Regulates the Human Osteocalcin Gene

REFERENCES

• Baldwin, A. S., and P. A. Sharp. 1988. Two transcription factors, NF-κB and H2TF1, interact with a single regulatory sequence in the class I major histocompatibility complex promoter. Proc. Natl. Acad. Sci. USA 85:723–727.
   PubMedGoogle Scholar
• Bauerle, P. A., and D. Baltimore. 1988. IκB: a specific inhibitor of the NF-κB transcription factor. Science 242:540–546.
   PubMed Web of Science ®Google Scholar
• Bertolini, D. R., G. E. Nedwin, T. S. Bringman, D. D. Smith, and G. R. Mundy. 1986. Stimulation of bone resorption and inhibition of bone formation in vitro by human tumour necrosis factors. Nature (London) 319:516–518.
   PubMed Web of Science ®Google Scholar
• Beutler, B. A., and A. Cerami. 1989. The biology of cachectin/ TNF: a primary mediator of the host response. Annu. Rev. Immunol. 7:625–656.
   PubMed Web of Science ®Google Scholar
• Beutler, B., J. Mahoney, N. Le Trang, P. Pekala, and A. Cerami. 1985. Purification of cachectin, a lipoprotein lipase-suppressing hormone secreted by endotoxin-induced RAW 264.7 cells. J. Exp. Med. 161:984–995.
   PubMed Web of Science ®Google Scholar
• Bornstein, P., J. McKay, J. K. Morishima, S. Devarayalu, and R. E. Gelinas. 1987. Regulatory elements in the first intron contribute to transcriptional control of the human α1(I) collagen gene. Proc. Natl. Acad. Sci. USA 84:8869–8873.
   PubMed Web of Science ®Google Scholar
• Bovagnet, P. F., E. E. Strehler, G. E. White, and M. A. Strehler-Page. 1987. Multiple positive and negative 5′ regulatory elements control the cell-type-specific expression of the embryonic skeletal myosin heavy-chain gene. Mol. Cell. Biol. 7:4377–4389.
   PubMedGoogle Scholar
• Carthew, R. W., L. A. Chodosh, and P. A. Sharp. 1985. An RNA polymerase II transcription factor binds to an upstream element in the adenovirus major late promoter. Cell 43:439–448.
   PubMed Web of Science ®Google Scholar
• Collart, M. A., P. Baeuerle, and P. Vassalli. 1990. Regulation of tumor necrosis factor alpha transcription in macrophages: involvement of four κB-like motifs and of constitutive and inducible forms of NF-κB. Mol. Cell. Biol. 10:1498–1506.
   PubMed Web of Science ®Google Scholar
• Dayer, J.-M., B. Beutler, and A. Cerami. 1986. Cachectin/tumor necrosis factor stimulates collagenase and prostaglandin E2 production by human synovial cells and dermal fibroblasts. J. Exp. Med. 12:2163–2168.
   Google Scholar
• Delmas, P. D., L. Malaval, M. E. Arlot, and P. J. Meunier. 1985. Serum bone Gla protein compared to bone histomorphometry in endocrine diseases. Bone 6:339–345.
   PubMed Web of Science ®Google Scholar
• Dignam, J. D., R. M. Lebovitz, and R. G. Roeder. 1983. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res. 11:1475–1489.
   PubMed Web of Science ®Google Scholar
• Duh, E. J., W. J. Maury, T. M. Folks, A. S. Fauci, and A. B. Rabson. 1989. Tumor necrosis factor a activates human immunodeficiency virus type 1 through induction of nuclear factor binding to the NF-κB sites in the long terminal repeat. Proc. Natl. Acad. Sci. USA 86:5974–5978.
   PubMed Web of Science ®Google Scholar
• Finer, M. H., S. Aho, L. C. Gerstenfield, H. Boedtker, and P. Doty. 1987. Unusual DNA sequences located within the pro-moter region and the first intron of the chicken pro-αl(I) collagen gene. J. Biol. Chem. 262:13323–13328.
   PubMedGoogle Scholar
• Fong, Y., L. L. Moldawer, M. A. Marano, H. Wei, A. Barber, K. Manogue, K. J. Tracey, G. Kuo, D. A. Fischman, and A. Cerami. 1989. Chronic cachectin/TNF or IL-lα induces cachexia with redistribution of body proteins. Am. J. Physiol. 256:R659-R665.
   PubMedGoogle Scholar
• Gao, L. H., and R. Wu. 1982. New rapid methods for DNA sequencing based on exonuclease III digestion followed by repair synthesis. Nucleic Acids Res. 10:2065–2084.
   PubMedGoogle Scholar
• Harrison, J. R., A. C. Lichtler, D. LaFrancis, D. W. Rowe, and B. E. Kream. 1991. Positive and negative regulation of α1(I) collagen promoter activity by interleukin-1α and tumor necrosis factor-α in MC3T3-E1 cells depends on cell maturation, abstr. 1. J. Bone Min. Res. 6(Suppl. 1):S83.
   Google Scholar
• Hauschka, P., J. Lian, and P. Gallop. 1975. Direct identification of the calcium-binding amino acid gamma-carboxyglutamate in mineralized tissue. Proc. Natl. Acad. Sci. USA 72:3925–3929.
   PubMed Web of Science ®Google Scholar
• Israel, A., O. LeBail, D. Hatat, J. Piette, M. Kieran, F. Logeat, D. Wallach, M. Fellous, and P. Kourilsky. 1989. TNF stimulates expression of mouse MHC class I genes by inducing an NF kappa B-like enhancer binding activity which displaces constitutive factors. EMBO J. 8:3793–3800.
   PubMedGoogle Scholar
• Jongeneel, C. V., A. N. Shakohov, S. A. Nedospasov, and J.-C. Cerottini. 1989. Molecular control of tissue-specific expression at the mouse TNF locus. Eur. J. Immunol. 19:549–552.
   PubMedGoogle Scholar
• Kieran, M., V. Blank, F. Logeat, J. Vanderkercklove, F. Lottspeich, O. LeBail, M. B. Urban, P. Kourilsky, P. A. Baeuerle, and A. Israel. 1990. The DNA binding subunit of NF-κB is identical to factor KBF1 and homologous to the rel oncogene product. Cell 62:1007–1018.
   PubMed Web of Science ®Google Scholar
• Kunkel, T. A. 1985. Rapid and efficient site-specific mutagenesis without phenotypic selection. Proc. Natl. Acad. Sci. USA 82:488–492.
   PubMed Web of Science ®Google Scholar
• Lenardo, M. J., and D. Baltimore. 1989. NF-kappa B: a pleio-tropic mediator of inducible and tissue-specific gene control. Cell 58:227–229.
   PubMed Web of Science ®Google Scholar
• Lenardo, M. J., C.-M. Fan, T. Maniatis, and D. Baltimore. 1989. The involvement of NF-κB in β-interferon gene regulation reveals its role as a widely inducible mediator of signal transduction. Cell 57:287–294.
   PubMed Web of Science ®Google Scholar
• Li, Y., and P. Stashenko. 1992. Proinflammatory cytokines TNF and IL-6, but not IL-1, down-regulate the osteocalcin promoter. J. Immunol. 148:788–794.
   PubMedGoogle Scholar
• Lian, J., C. Stewart, E. Puchacz, S. Mackowiak, V. Shalhoub, D. Collart, G. Zambetti, and G. Stein. 1989. Structure of the rat osteocalcin gene and regulation of vitamin D-dependent expression. Proc. Natl. Acad. Sci. USA 86:1143–1147.
   PubMedGoogle Scholar
• Lowenthal, J. W., D. W. Ballard, E. Bohnlein, and W. C. Greene. 1989. Tumor necrosis factor a induces proteins that bind specifically to κB-like enhancer elements and regulate interleukin 2 receptor α-chain gene expression in primary human T lymphocytes. Proc. Natl. Acad. Sci. USA 86:2331–2335.
   PubMedGoogle Scholar
• Moldawer, L. L., M. Georgieff, and K. G. Lundholm. 1987. Interleukin 1, tumor necrosis factor-α, and the pathogenesis of cancer cachexia. Clin. Physiol. 7:263–274.
   PubMedGoogle Scholar
• Morrison, N. A., J. Shine, J.-C. Fragonas, V. Verkest, M. L. McMenemy, and J. A. Eisman. 1989. 1,25-Dihydroxyvitamin D-responsive element and glucocorticoid repression in the osteocalcin gene. Science 246:1158–1161.
   PubMed Web of Science ®Google Scholar
• Nanes, M. S., J. Rubin, G. Titus, G. Hendy, and B. D. Catherwood. 1991. Tumor necrosis factor alpha inhibits 1,25 dihydroxyvitamin D3-stimulated bone Gla protein synthesis in rat osteosarcoma cells (ROS 17/2.8) by a pretranslational mechanism. Endocrinology 128:2577–2584.
   PubMedGoogle Scholar
• Neumann, J. R., A. C. Morency, and O. K. Russian. 1987. A novel rapid assay for chloramphenicol acetyltransferase gene expression. Biotechniques 5:444–446.
   Web of Science ®Google Scholar
• Ohdama, S., S. Takano, K. Ohashi, S. Miyake, and N. Aoki. 1991. Pentoxifylline prevents tumor necrosis factor-induced suppression of endothelial cell surface thrombomodulin. Thrombosis Res. 62:745–755.
   PubMed Web of Science ®Google Scholar
• Oliff, A., D. Defeo-Jones, M. Boyer, D. Martinez, D. Kiefer, G. Vuocolo, A. Wolfe, and S. H. Socher. 1987. Tumors secreting human TNF/cachectin induce cachexia in mice. Cell 50:555–563.
   PubMed Web of Science ®Google Scholar
• Osborn, L., S. Kunkel, and G. J. Nabel. 1989. Tumor necrosis factor α and interleukin 1 stimulate the human immunodefi-ciency virus enhancer by activation of the nuclear factor κB. Proc. Natl. Acad. Sci. USA 86:2336–2340.
   PubMed Web of Science ®Google Scholar
• Ozono, K., J. Liao, S. A. Kerner, R. A. Scott, and J. W. Pike. 1990. The vitamin D-responsive element in the human osteocalcin gene. J. Biol. Chem. 265:21881–21888.
   PubMedGoogle Scholar
• Pfizenmaier, K., P. Scheurich, C. Schluter, and M. Kronke. 1987. Tumor necrosis factor enhances HLA-A,B,C and HLA-DR gene expression in human tumor cells. J. Immunol. 138:975–980.
   PubMed Web of Science ®Google Scholar
• Robins, D. M., S. Ripley, A. S. Henderson, and R. Axel. 1981. Transforming DNA integrates into the host chromosome. Cell 23:29–39.
   PubMed Web of Science ®Google Scholar
• Saklatvala, J. 1986. Tumour necrosis factor α stimulates resorption and inhibits synthesis of proteoglycan in cartilage. Nature (London) 322:547–549.
   PubMed Web of Science ®Google Scholar
• Sanger, F., S. Nicklen, and A. R. Coulson. 1977. DNA sequencing with chain-terminating inhibitors. Proc. Natl. Acad. Sci. USA 74:5463–5467.
   PubMed Web of Science ®Google Scholar
• Sen, R., and D. Baltimore. 1986. Inducibility of kappa immunoglobulin enhancer-binding protein NF-κB, a posttranslational mechanism. Cell 47:921–928.
   PubMed Web of Science ®Google Scholar
• Shannon, M. F., L. M. Pell, M. J. Lenardo, E. S. Kuczek, F. S. Occhiodoro, S. M. Dunn, and M. A. Vadas. 1990. A novel tumor necrosis factor-responsive transcription factor which recognizes a regulatory element in hemopoietic growth factor genes. Mol. Cell. Biol. 10:2950–2959.
   PubMed Web of Science ®Google Scholar
• Stashenko, P., F. E. Dewhirst, W. J. Peros, R. L. Kent, and J. M. Ago. 1987. Synergistic interactions between interleukin 1, tumor necrosis factor, and lymphotoxin in bone resorption. J. Immunol. 138:1464–1469.
   PubMed Web of Science ®Google Scholar
• Stashenko, P., M. S. Obernesser, and F. E. Dewhirst. 1989. Effect of immune cytokines on bone. Immunol. Invest. 18:239–249.
   PubMed Web of Science ®Google Scholar
• Tracey, K. 1992. The acute and chronic pathophysiologic effects of TNF: mediation of septic shock and wasting (cachexia), p. 255–273. In B. Beutler (ed.), Tumor necrosis factors: the molecules and their emerging role in medicine. Raven Press, Ltd., New York.
   Google Scholar
• Watt, R., K. Nishikura, J. Sorrentino, A. Ar-Rushdi, C. M. Croce, and G. Rovera. 1983. The structure and nucleotide sequence of the 5′ end of the human c-myc oncogene. Proc. Natl. Acad. Sci. USA 80:6307–6311.
   PubMedGoogle Scholar
• Weiss, M. J., P. S. Henthorn, K. Ray, B. Lamb, T. Kadesch, and H. Harris. 1988. Structure of the human liver/bone/kidney alkaline phosphatase gene. J. Biol. Chem. 263:12002–12010.
   PubMed Web of Science ®Google Scholar
• Young, M. F., D. M. Findlay, P. Dominguez, P. D. Burbelo, C. McQuillan, J. B. Kopp, P. Gehron-Robey, and J. D. Termine. 1988. Osteonectin promoter. J. Biol. Chem. 264:450–456.
   Google Scholar
• Zabel, U., and P. Baeuerle. 1990. Purified IκB can dissociate the complex of the NF-κB transcription factor with its cognate DNA. Cell 61:255–265.
   PubMed Web of Science ®Google Scholar